| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vasodilation | 19 | 2023 | 19 | 7.930 |
Why?
|
| Coronary Vessels | 10 | 2022 | 15 | 4.940 |
Why?
|
| Arterioles | 15 | 2023 | 15 | 4.720 |
Why?
|
| Telomerase | 8 | 2021 | 18 | 4.560 |
Why?
|
| Coronary Artery Disease | 10 | 2023 | 30 | 3.610 |
Why?
|
| Humans | 59 | 2023 | 4119 | 3.290 |
Why?
|
| Antineoplastic Agents | 6 | 2022 | 77 | 3.150 |
Why?
|
| Animals | 42 | 2023 | 1545 | 2.910 |
Why?
|
| Nitric Oxide | 11 | 2023 | 18 | 2.810 |
Why?
|
| Neoplasms | 8 | 2022 | 135 | 2.810 |
Why?
|
| Microcirculation | 9 | 2022 | 11 | 2.780 |
Why?
|
| Adipose Tissue | 7 | 2022 | 40 | 2.750 |
Why?
|
| Microvessels | 6 | 2023 | 8 | 2.690 |
Why?
|
| Male | 33 | 2022 | 1811 | 2.530 |
Why?
|
| Endothelium, Vascular | 10 | 2022 | 18 | 2.460 |
Why?
|
| Endothelial Cells | 6 | 2021 | 26 | 2.440 |
Why?
|
| Mitochondria | 8 | 2021 | 150 | 2.420 |
Why?
|
| Middle Cerebral Artery | 4 | 2021 | 4 | 2.220 |
Why?
|
| Hypertension | 4 | 2022 | 15 | 2.150 |
Why?
|
| Computational Biology | 8 | 2021 | 164 | 1.860 |
Why?
|
| Mesenteric Arteries | 3 | 2019 | 3 | 1.830 |
Why?
|
| Female | 23 | 2022 | 2147 | 1.790 |
Why?
|
| Heart Diseases | 3 | 2022 | 6 | 1.770 |
Why?
|
| Aging | 4 | 2023 | 92 | 1.730 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 46 | 1.720 |
Why?
|
| Angiotensin II | 4 | 2017 | 7 | 1.700 |
Why?
|
| Hydrogen Peroxide | 9 | 2021 | 22 | 1.700 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2022 | 9 | 1.630 |
Why?
|
| Blood Pressure | 4 | 2022 | 29 | 1.590 |
Why?
|
| Middle Aged | 16 | 2022 | 843 | 1.500 |
Why?
|
| Cerebrovascular Circulation | 3 | 2021 | 5 | 1.490 |
Why?
|
| Vasodilator Agents | 8 | 2022 | 8 | 1.450 |
Why?
|
| Signal Transduction | 9 | 2023 | 261 | 1.420 |
Why?
|
| Mice | 20 | 2023 | 737 | 1.240 |
Why?
|
| Oxidative Stress | 6 | 2022 | 50 | 1.180 |
Why?
|
| Protein Interaction Mapping | 5 | 2014 | 24 | 1.160 |
Why?
|
| Sodium Chloride | 4 | 2015 | 9 | 1.130 |
Why?
|
| Quantitative Trait Loci | 5 | 2014 | 90 | 1.110 |
Why?
|
| Cardiovascular System | 3 | 2022 | 4 | 1.110 |
Why?
|
| Algorithms | 5 | 2021 | 165 | 1.070 |
Why?
|
| Lung | 3 | 2021 | 35 | 1.060 |
Why?
|
| Renin | 3 | 2021 | 5 | 1.060 |
Why?
|
| Autophagy | 3 | 2020 | 20 | 1.050 |
Why?
|
| Cardiotoxicity | 7 | 2022 | 8 | 1.050 |
Why?
|
| Hyperoxia | 2 | 2021 | 2 | 0.990 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 67 | 0.980 |
Why?
|
| Chromosome Mapping | 5 | 2013 | 146 | 0.980 |
Why?
|
| Hypertension, Renovascular | 2 | 2014 | 2 | 0.960 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2014 | 3 | 0.960 |
Why?
|
| Aged | 11 | 2021 | 580 | 0.950 |
Why?
|
| Enzyme Inhibitors | 4 | 2020 | 16 | 0.940 |
Why?
|
| Genomics | 5 | 2021 | 143 | 0.930 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2023 | 1 | 0.920 |
Why?
|
| Cells, Cultured | 10 | 2023 | 261 | 0.920 |
Why?
|
| Anthracyclines | 2 | 2022 | 11 | 0.920 |
Why?
|
| Databases, Genetic | 5 | 2013 | 62 | 0.890 |
Why?
|
| Longevity | 1 | 2023 | 40 | 0.890 |
Why?
|
| Mitochondrial Dynamics | 2 | 2019 | 2 | 0.880 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2021 | 1 | 0.840 |
Why?
|
| Gene Expression Profiling | 12 | 2022 | 345 | 0.830 |
Why?
|
| Lung Injury | 1 | 2021 | 1 | 0.830 |
Why?
|
| Computer Simulation | 4 | 2015 | 96 | 0.810 |
Why?
|
| Adult | 9 | 2022 | 944 | 0.790 |
Why?
|
| Arterial Pressure | 1 | 2021 | 1 | 0.790 |
Why?
|
| Models, Genetic | 5 | 2015 | 117 | 0.780 |
Why?
|
| Mitochondria, Heart | 2 | 2018 | 14 | 0.770 |
Why?
|
| Software | 2 | 2022 | 133 | 0.770 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2020 | 13 | 0.770 |
Why?
|
| Rats, Inbred Dahl | 3 | 2021 | 3 | 0.770 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 17 | 0.760 |
Why?
|
| Case-Control Studies | 6 | 2022 | 322 | 0.760 |
Why?
|
| Coatomer Protein | 2 | 2017 | 2 | 0.760 |
Why?
|
| Gene Regulatory Networks | 3 | 2022 | 70 | 0.750 |
Why?
|
| PPAR gamma | 3 | 2009 | 8 | 0.750 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2021 | 3 | 0.740 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 143 | 0.740 |
Why?
|
| Rats | 6 | 2023 | 164 | 0.730 |
Why?
|
| Protein Interaction Maps | 3 | 2021 | 19 | 0.730 |
Why?
|
| Doxorubicin | 1 | 2019 | 13 | 0.710 |
Why?
|
| Proteins | 4 | 2014 | 77 | 0.710 |
Why?
|
| Schizosaccharomyces | 2 | 2020 | 7 | 0.700 |
Why?
|
| Heart | 1 | 2019 | 13 | 0.700 |
Why?
|
| Atherosclerosis | 1 | 2018 | 23 | 0.650 |
Why?
|
| Host-Pathogen Interactions | 2 | 2022 | 31 | 0.650 |
Why?
|
| Acetylcholine | 5 | 2022 | 5 | 0.640 |
Why?
|
| In Vitro Techniques | 4 | 2020 | 53 | 0.640 |
Why?
|
| Mutation, Missense | 2 | 2020 | 124 | 0.640 |
Why?
|
| Cell Cycle Proteins | 2 | 2014 | 33 | 0.620 |
Why?
|
| Models, Molecular | 2 | 2014 | 50 | 0.610 |
Why?
|
| Orientia tsutsugamushi | 1 | 2017 | 1 | 0.600 |
Why?
|
| Ankyrins | 1 | 2017 | 3 | 0.600 |
Why?
|
| Golgi Apparatus | 1 | 2017 | 6 | 0.600 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 22 | 0.590 |
Why?
|
| Coronary Circulation | 3 | 2020 | 6 | 0.590 |
Why?
|
| Caloric Restriction | 3 | 2023 | 6 | 0.590 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 48 | 0.580 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 1 | 0.580 |
Why?
|
| Enzyme Activators | 1 | 2016 | 1 | 0.580 |
Why?
|
| Angiotensin I | 1 | 2016 | 1 | 0.570 |
Why?
|
| Schizosaccharomyces pombe Proteins | 2 | 2020 | 3 | 0.560 |
Why?
|
| Peptide Fragments | 1 | 2016 | 26 | 0.560 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 5 | 0.560 |
Why?
|
| Groundwater | 1 | 2015 | 1 | 0.540 |
Why?
|
| Water Wells | 1 | 2015 | 1 | 0.540 |
Why?
|
| Water Microbiology | 1 | 2015 | 3 | 0.530 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2021 | 16 | 0.530 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2021 | 4 | 0.520 |
Why?
|
| Models, Biological | 2 | 2017 | 115 | 0.520 |
Why?
|
| RNA, Fungal | 1 | 2014 | 12 | 0.510 |
Why?
|
| Centrosome | 1 | 2014 | 9 | 0.500 |
Why?
|
| Organ Specificity | 2 | 2016 | 37 | 0.500 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 13 | 0.480 |
Why?
|
| Proteomics | 5 | 2021 | 77 | 0.480 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 26 | 0.470 |
Why?
|
| Binding Sites | 1 | 2013 | 73 | 0.470 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 417 | 0.470 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 9 | 0.450 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 102 | 0.450 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2012 | 1 | 0.450 |
Why?
|
| Gene Products, gag | 1 | 2012 | 1 | 0.450 |
Why?
|
| Virus Assembly | 1 | 2012 | 1 | 0.450 |
Why?
|
| Cell Nucleolus | 1 | 2012 | 2 | 0.450 |
Why?
|
| Ribosomal Proteins | 1 | 2012 | 6 | 0.450 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 7 | 0.440 |
Why?
|
| Proteome | 5 | 2020 | 57 | 0.430 |
Why?
|
| Population | 1 | 2012 | 2 | 0.430 |
Why?
|
| Acetylglucosamine | 1 | 2012 | 1 | 0.430 |
Why?
|
| Hexosamines | 1 | 2012 | 1 | 0.430 |
Why?
|
| Cell Differentiation | 1 | 2013 | 199 | 0.420 |
Why?
|
| Transcription Factors | 2 | 2013 | 256 | 0.420 |
Why?
|
| Hyperglycemia | 1 | 2012 | 7 | 0.420 |
Why?
|
| Epistasis, Genetic | 1 | 2012 | 19 | 0.420 |
Why?
|
| RNA, Messenger | 5 | 2021 | 263 | 0.420 |
Why?
|
| Rats, Transgenic | 2 | 2021 | 8 | 0.420 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 92 | 0.420 |
Why?
|
| Gene Frequency | 1 | 2012 | 120 | 0.410 |
Why?
|
| Obesity | 1 | 2012 | 86 | 0.410 |
Why?
|
| Time Factors | 3 | 2022 | 115 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 226 | 0.410 |
Why?
|
| Prostatic Neoplasms | 2 | 2021 | 18 | 0.400 |
Why?
|
| Disease Progression | 2 | 2021 | 72 | 0.400 |
Why?
|
| Nitric Oxide Synthase | 3 | 2020 | 5 | 0.390 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 56 | 0.390 |
Why?
|
| Reactive Oxygen Species | 5 | 2018 | 40 | 0.390 |
Why?
|
| Homeostasis | 2 | 2021 | 50 | 0.390 |
Why?
|
| DNA, Mitochondrial | 2 | 2022 | 65 | 0.380 |
Why?
|
| Genetic Variation | 4 | 2016 | 189 | 0.370 |
Why?
|
| RNA | 2 | 2022 | 54 | 0.360 |
Why?
|
| Acute Kidney Injury | 2 | 2020 | 3 | 0.360 |
Why?
|
| Hypoxia | 2 | 2020 | 6 | 0.360 |
Why?
|
| Catalase | 3 | 2020 | 6 | 0.350 |
Why?
|
| Polyethylene Glycols | 3 | 2020 | 7 | 0.350 |
Why?
|
| Systems Biology | 2 | 2021 | 26 | 0.350 |
Why?
|
| Genome, Human | 1 | 2009 | 104 | 0.350 |
Why?
|
| Models, Theoretical | 2 | 2013 | 26 | 0.340 |
Why?
|
| Cerebrovascular Disorders | 1 | 2008 | 1 | 0.330 |
Why?
|
| MicroRNAs | 2 | 2023 | 82 | 0.330 |
Why?
|
| Dietary Fats | 1 | 2008 | 10 | 0.330 |
Why?
|
| Sequence Analysis, RNA | 2 | 2022 | 90 | 0.330 |
Why?
|
| Adaptation, Physiological | 2 | 2021 | 27 | 0.330 |
Why?
|
| Protein Binding | 4 | 2017 | 97 | 0.330 |
Why?
|
| Adolescent | 3 | 2019 | 493 | 0.330 |
Why?
|
| Diet, Sodium-Restricted | 2 | 2021 | 2 | 0.320 |
Why?
|
| Infant, Newborn | 2 | 2019 | 119 | 0.320 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2019 | 9 | 0.320 |
Why?
|
| Oxygen | 3 | 2018 | 24 | 0.310 |
Why?
|
| Infant | 2 | 2019 | 267 | 0.310 |
Why?
|
| Genome | 3 | 2013 | 77 | 0.310 |
Why?
|
| Bias | 2 | 2021 | 4 | 0.310 |
Why?
|
| Child, Preschool | 2 | 2019 | 378 | 0.300 |
Why?
|
| DNA Methylation | 2 | 2021 | 186 | 0.300 |
Why?
|
| Protein Transport | 3 | 2017 | 31 | 0.290 |
Why?
|
| Child | 2 | 2019 | 557 | 0.290 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 92 | 0.280 |
Why?
|
| Transcriptome | 4 | 2020 | 201 | 0.280 |
Why?
|
| Mutation | 7 | 2023 | 608 | 0.260 |
Why?
|
| Insulin | 2 | 2023 | 61 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 111 | 0.260 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 111 | 0.260 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2018 | 31 | 0.250 |
Why?
|
| Oxidation-Reduction | 3 | 2019 | 58 | 0.250 |
Why?
|
| Silent Mutation | 1 | 2023 | 1 | 0.230 |
Why?
|
| Somatomedins | 1 | 2023 | 1 | 0.230 |
Why?
|
| Nucleosomes | 1 | 2023 | 8 | 0.230 |
Why?
|
| RNA Polymerase II | 1 | 2023 | 12 | 0.230 |
Why?
|
| Cell Division | 1 | 2023 | 22 | 0.230 |
Why?
|
| B-Lymphocytes | 1 | 2023 | 60 | 0.230 |
Why?
|
| Drosophila melanogaster | 1 | 2023 | 25 | 0.230 |
Why?
|
| Temperature | 1 | 2003 | 29 | 0.230 |
Why?
|
| Air Pollutants | 1 | 2003 | 12 | 0.230 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 43 | 0.230 |
Why?
|
| Histones | 1 | 2023 | 36 | 0.220 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2022 | 2 | 0.220 |
Why?
|
| Glycolysis | 2 | 2020 | 11 | 0.220 |
Why?
|
| Models, Statistical | 3 | 2013 | 46 | 0.220 |
Why?
|
| Hormones | 1 | 2022 | 2 | 0.220 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 46 | 0.220 |
Why?
|
| Cancer Survivors | 1 | 2022 | 2 | 0.210 |
Why?
|
| Atrial Appendage | 1 | 2022 | 1 | 0.210 |
Why?
|
| Data Interpretation, Statistical | 1 | 2021 | 17 | 0.210 |
Why?
|
| Capillary Permeability | 1 | 2021 | 1 | 0.210 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2021 | 5 | 0.210 |
Why?
|
| Autophagy-Related Proteins | 1 | 2021 | 3 | 0.210 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 161 | 0.210 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 50 | 0.210 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 16 | 0.210 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 17 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2020 | 552 | 0.210 |
Why?
|
| Membrane Transport Proteins | 1 | 2021 | 12 | 0.210 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 25 | 0.210 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 29 | 0.200 |
Why?
|
| Liver | 1 | 2021 | 61 | 0.200 |
Why?
|
| Toxicity Tests | 1 | 2021 | 2 | 0.200 |
Why?
|
| Aorta | 2 | 2013 | 11 | 0.200 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 13 | 0.200 |
Why?
|
| Young Adult | 3 | 2016 | 345 | 0.200 |
Why?
|
| Brain | 1 | 2021 | 153 | 0.190 |
Why?
|
| Mice, Knockout | 2 | 2018 | 149 | 0.190 |
Why?
|
| Cardiotonic Agents | 1 | 2020 | 3 | 0.190 |
Why?
|
| Imatinib Mesylate | 1 | 2020 | 7 | 0.190 |
Why?
|
| Pyrimidines | 1 | 2020 | 10 | 0.190 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 13 | 0.190 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 98 | 0.190 |
Why?
|
| Heart Failure | 1 | 2020 | 16 | 0.190 |
Why?
|
| Phylogeny | 4 | 2016 | 208 | 0.190 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 35 | 0.190 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 79 | 0.190 |
Why?
|
| Pyruvate Kinase | 1 | 2020 | 2 | 0.190 |
Why?
|
| Carbon | 1 | 2020 | 7 | 0.190 |
Why?
|
| Ischemic Preconditioning | 1 | 2020 | 1 | 0.190 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 2 | 0.190 |
Why?
|
| Biomarkers | 2 | 2018 | 188 | 0.190 |
Why?
|
| RNA Interference | 2 | 2017 | 48 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2020 | 18 | 0.180 |
Why?
|
| Enzyme Activation | 2 | 2016 | 17 | 0.180 |
Why?
|
| Diabetic Angiopathies | 1 | 2019 | 2 | 0.180 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 8 | 0.180 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 7 | 0.180 |
Why?
|
| Microscopy, Electron | 1 | 2019 | 18 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 7 | 0.180 |
Why?
|
| Protective Agents | 1 | 2019 | 1 | 0.180 |
Why?
|
| Age Factors | 1 | 2019 | 56 | 0.180 |
Why?
|
| NAD | 1 | 2019 | 23 | 0.180 |
Why?
|
| Aorta, Thoracic | 2 | 2009 | 4 | 0.180 |
Why?
|
| Glucose | 1 | 2019 | 36 | 0.180 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 52 | 0.170 |
Why?
|
| HeLa Cells | 2 | 2017 | 62 | 0.170 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2020 | 30 | 0.170 |
Why?
|
| Sequence Alignment | 3 | 2009 | 83 | 0.170 |
Why?
|
| Energy Metabolism | 1 | 2019 | 47 | 0.170 |
Why?
|
| Arteries | 1 | 2018 | 2 | 0.170 |
Why?
|
| Lysophospholipids | 1 | 2018 | 8 | 0.170 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2018 | 5 | 0.170 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2018 | 4 | 0.170 |
Why?
|
| Blotting, Western | 2 | 2016 | 38 | 0.170 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 78 | 0.170 |
Why?
|
| Proteinuria | 1 | 2018 | 2 | 0.160 |
Why?
|
| Nephrons | 1 | 2018 | 2 | 0.160 |
Why?
|
| Glomerulonephritis | 1 | 2018 | 3 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 19 | 0.160 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 2 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 5 | 0.160 |
Why?
|
| Cell Proliferation | 1 | 2018 | 129 | 0.160 |
Why?
|
| HEK293 Cells | 2 | 2015 | 64 | 0.160 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 35 | 0.160 |
Why?
|
| Cell Nucleus | 1 | 2017 | 36 | 0.160 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 4 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 12 | 0.150 |
Why?
|
| Scrub Typhus | 1 | 2017 | 1 | 0.150 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2017 | 1 | 0.150 |
Why?
|
| Protein Domains | 1 | 2017 | 6 | 0.150 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 6 | 0.150 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2016 | 1 | 0.150 |
Why?
|
| Telomere Homeostasis | 1 | 2016 | 4 | 0.140 |
Why?
|
| Telomere Shortening | 1 | 2016 | 7 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 13 | 0.140 |
Why?
|
| Heart Atria | 1 | 2016 | 7 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 43 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 16 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2016 | 30 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 37 | 0.140 |
Why?
|
| Blood Circulation | 1 | 2016 | 8 | 0.140 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2012 | 11 | 0.140 |
Why?
|
| Population Dynamics | 1 | 2015 | 3 | 0.130 |
Why?
|
| Bardet-Biedl Syndrome | 1 | 2015 | 2 | 0.130 |
Why?
|
| Arabidopsis | 1 | 2016 | 97 | 0.130 |
Why?
|
| Receptor, Insulin | 1 | 2015 | 6 | 0.130 |
Why?
|
| Molecular Typing | 1 | 2015 | 7 | 0.130 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 11 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 54 | 0.130 |
Why?
|
| Pterins | 1 | 2014 | 1 | 0.130 |
Why?
|
| Multiple Trauma | 1 | 2014 | 1 | 0.130 |
Why?
|
| Muramidase | 1 | 2014 | 3 | 0.130 |
Why?
|
| Superoxides | 1 | 2014 | 8 | 0.130 |
Why?
|
| Endocytosis | 1 | 2014 | 8 | 0.130 |
Why?
|
| Germany | 1 | 2015 | 251 | 0.130 |
Why?
|
| Hippocampus | 2 | 2015 | 48 | 0.130 |
Why?
|
| Uranium | 1 | 2014 | 1 | 0.130 |
Why?
|
| Manganese Compounds | 1 | 2014 | 1 | 0.130 |
Why?
|
| Sphingosine | 1 | 2014 | 8 | 0.120 |
Why?
|
| Schizophrenia | 1 | 2015 | 74 | 0.120 |
Why?
|
| Soil Microbiology | 1 | 2014 | 18 | 0.120 |
Why?
|
| Microbiota | 1 | 2015 | 79 | 0.120 |
Why?
|
| Fungi | 1 | 2014 | 20 | 0.120 |
Why?
|
| Chromosome Pairing | 1 | 2013 | 1 | 0.120 |
Why?
|
| Meiotic Prophase I | 1 | 2013 | 1 | 0.120 |
Why?
|
| Spermatocytes | 1 | 2013 | 2 | 0.120 |
Why?
|
| Phenylephrine | 1 | 2013 | 1 | 0.120 |
Why?
|
| Meiosis | 1 | 2013 | 8 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 249 | 0.120 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 1 | 0.120 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 4 | 0.120 |
Why?
|
| Tropomyosin | 1 | 2013 | 14 | 0.120 |
Why?
|
| Bacteria | 1 | 2014 | 86 | 0.120 |
Why?
|
| Myocardium | 1 | 2013 | 28 | 0.120 |
Why?
|
| Bayes Theorem | 2 | 2011 | 42 | 0.110 |
Why?
|
| Cell Lineage | 1 | 2013 | 42 | 0.110 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2012 | 3 | 0.110 |
Why?
|
| Protein Sorting Signals | 1 | 2012 | 5 | 0.110 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2012 | 13 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 14 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 95 | 0.110 |
Why?
|
| Parks, Recreational | 2 | 2022 | 2 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 2012 | 2 | 0.110 |
Why?
|
| Eating | 1 | 2012 | 6 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2012 | 47 | 0.110 |
Why?
|
| Body Weight | 1 | 2012 | 13 | 0.110 |
Why?
|
| Cell Line | 1 | 2012 | 137 | 0.110 |
Why?
|
| Fibroblasts | 2 | 2015 | 71 | 0.110 |
Why?
|
| Benzo(a)pyrene | 1 | 2011 | 1 | 0.100 |
Why?
|
| Heterozygote | 1 | 2012 | 94 | 0.100 |
Why?
|
| Haplotypes | 1 | 2012 | 122 | 0.100 |
Why?
|
| Pedigree | 1 | 2012 | 304 | 0.100 |
Why?
|
| Dilatation | 2 | 2023 | 2 | 0.100 |
Why?
|
| Genotype | 1 | 2012 | 320 | 0.100 |
Why?
|
| Chromosomes, Mammalian | 1 | 2010 | 2 | 0.100 |
Why?
|
| Sample Size | 1 | 2010 | 7 | 0.100 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2010 | 14 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2018 | 48 | 0.100 |
Why?
|
| Databases, Protein | 1 | 2009 | 10 | 0.090 |
Why?
|
| Benchmarking | 1 | 2009 | 7 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2009 | 18 | 0.090 |
Why?
|
| Phenotype | 3 | 2020 | 479 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 210 | 0.090 |
Why?
|
| Serotonin Agents | 1 | 2008 | 1 | 0.080 |
Why?
|
| Hypertrophy | 1 | 2008 | 2 | 0.080 |
Why?
|
| Dinoprost | 1 | 2008 | 3 | 0.080 |
Why?
|
| Serotonin | 1 | 2008 | 6 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 10 | 0.080 |
Why?
|
| Endothelin-1 | 1 | 2008 | 5 | 0.080 |
Why?
|
| Genes, Dominant | 1 | 2008 | 17 | 0.080 |
Why?
|
| Up-Regulation | 3 | 2018 | 62 | 0.080 |
Why?
|
| Statistics as Topic | 2 | 2017 | 10 | 0.080 |
Why?
|
| Synovial Membrane | 1 | 2007 | 1 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2007 | 5 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 4 | 0.070 |
Why?
|
| Sequence Analysis | 1 | 2006 | 11 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2006 | 20 | 0.070 |
Why?
|
| Antioxidants | 2 | 2018 | 7 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 301 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2020 | 11 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 6 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2023 | 5 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2015 | 14 | 0.060 |
Why?
|
| Air Movements | 1 | 2003 | 1 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2003 | 15 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 17 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2023 | 38 | 0.060 |
Why?
|
| Exercise | 1 | 2022 | 11 | 0.060 |
Why?
|
| Endothelium | 1 | 2022 | 6 | 0.060 |
Why?
|
| Quality of Life | 1 | 2022 | 21 | 0.060 |
Why?
|
| Gene Expression | 3 | 2009 | 138 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2016 | 138 | 0.050 |
Why?
|
| American Heart Association | 1 | 2021 | 1 | 0.050 |
Why?
|
| United States | 1 | 2021 | 10 | 0.050 |
Why?
|
| Epigenomics | 1 | 2021 | 24 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2021 | 47 | 0.050 |
Why?
|
| Prostate | 1 | 2020 | 2 | 0.050 |
Why?
|
| Proteogenomics | 1 | 2020 | 3 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2020 | 14 | 0.050 |
Why?
|
| Lysosomes | 1 | 2020 | 7 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2020 | 18 | 0.050 |
Why?
|
| Inflammation | 1 | 2022 | 179 | 0.050 |
Why?
|
| Fermentation | 1 | 2020 | 4 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 148 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 1 | 0.040 |
Why?
|
| Complement Activation | 1 | 2018 | 4 | 0.040 |
Why?
|
| Proteolysis | 1 | 2018 | 12 | 0.040 |
Why?
|
| Cisplatin | 1 | 2018 | 20 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 186 | 0.040 |
Why?
|
| Thenoyltrifluoroacetone | 1 | 2018 | 1 | 0.040 |
Why?
|
| Oxazines | 1 | 2018 | 2 | 0.040 |
Why?
|
| Antimycin A | 1 | 2018 | 6 | 0.040 |
Why?
|
| Rotenone | 1 | 2018 | 11 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 6 | 0.040 |
Why?
|
| Potassium Cyanide | 1 | 2018 | 3 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 64 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lysosome-Associated Membrane Glycoproteins | 1 | 2018 | 4 | 0.040 |
Why?
|
| Biological Variation, Individual | 1 | 2018 | 2 | 0.040 |
Why?
|
| Podocytes | 1 | 2018 | 4 | 0.040 |
Why?
|
| WT1 Proteins | 1 | 2018 | 6 | 0.040 |
Why?
|
| Nephrotic Syndrome | 1 | 2018 | 8 | 0.040 |
Why?
|
| Proteostasis | 1 | 2018 | 4 | 0.040 |
Why?
|
| Dynamins | 1 | 2018 | 1 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 13 | 0.040 |
Why?
|
| Biotinylation | 1 | 2017 | 1 | 0.040 |
Why?
|
| Nuclear Localization Signals | 1 | 2017 | 2 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2017 | 6 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2017 | 8 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2017 | 15 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2017 | 15 | 0.040 |
Why?
|
| Peptides | 1 | 2017 | 38 | 0.040 |
Why?
|
| Biological Availability | 1 | 2017 | 3 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 11 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 11 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 32 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 27 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2016 | 2 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2016 | 7 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2016 | 21 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2016 | 6 | 0.040 |
Why?
|
| Acclimatization | 1 | 2016 | 5 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2016 | 14 | 0.040 |
Why?
|
| Arabidopsis Proteins | 1 | 2016 | 30 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2016 | 42 | 0.040 |
Why?
|
| Genes, Plant | 1 | 2016 | 55 | 0.030 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2016 | 86 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2015 | 20 | 0.030 |
Why?
|
| Alleles | 1 | 2016 | 221 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 114 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2015 | 1 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 12 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 21 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 8 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 20 | 0.030 |
Why?
|
| Listeria monocytogenes | 1 | 2014 | 8 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 103 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2014 | 10 | 0.030 |
Why?
|
| Leukocytes | 1 | 2014 | 22 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 39 | 0.030 |
Why?
|
| Biodegradation, Environmental | 1 | 2014 | 1 | 0.030 |
Why?
|
| Mining | 1 | 2014 | 1 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 1 | 0.030 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2014 | 1 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 18 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 14 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2014 | 4 | 0.030 |
Why?
|
| Soil | 1 | 2014 | 14 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 24 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 122 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2014 | 57 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2013 | 3 | 0.030 |
Why?
|
| Synaptonemal Complex | 1 | 2013 | 2 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 2013 | 3 | 0.030 |
Why?
|
| Telomere | 1 | 2013 | 10 | 0.030 |
Why?
|
| Centromere | 1 | 2013 | 8 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 11 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 14 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2013 | 37 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2011 | 4 | 0.030 |
Why?
|
| ROC Curve | 1 | 2011 | 12 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 21 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2011 | 62 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 15 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 5 | 0.020 |
Why?
|
| Inbreeding | 1 | 2010 | 15 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2009 | 3 | 0.020 |
Why?
|
| Ligands | 1 | 2009 | 10 | 0.020 |
Why?
|
| Aspirin | 1 | 2009 | 2 | 0.020 |
Why?
|
| Models, Animal | 1 | 2009 | 15 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2009 | 2 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2009 | 12 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2009 | 9 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2009 | 19 | 0.020 |
Why?
|
| Internet | 1 | 2009 | 19 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 22 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 35 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2009 | 13 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 50 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 51 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 68 | 0.020 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2007 | 7 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 93 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 40 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2006 | 12 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 21 | 0.020 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2003 | 6 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2003 | 11 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 22 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Synteny | 1 | 2003 | 11 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2003 | 14 | 0.010 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2003 | 9 | 0.010 |
Why?
|
| Vesicular Transport Proteins | 1 | 2003 | 17 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 45 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2003 | 31 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 64 | 0.010 |
Why?
|
| Introns | 1 | 2003 | 60 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 102 | 0.010 |
Why?
|
